National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, & ebrary, Inc. (2011). Risk-characterization framework for decision-making at the food and drug administration. National Academies Press.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, and Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. Washington, DC: National Academies Press, 2011.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, and Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. National Academies Press, 2011.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.